Improvement of spontaneous locomotor activity with JAK inhibition by JTE-052 in rat adjuvant-induced arthritis

Autor: Yukari Kimoto, Wataru Amano, Keisuke Nozawa, Akira Matsuo, Yuichi Shinozaki, Atsuo Tanimoto, Takayuki Yamaguchi, Mutsuyoshi Matsushita
Jazyk: angličtina
Předmět:
musculoskeletal diseases
Quality of life
Male
medicine.medical_specialty
Pain-related behavior
Time Factors
JTE-052
Freund's Adjuvant
Anti-Inflammatory Agents
Arthritis
Administration
Oral

Inflammation
Pharmacology
JAK inhibition
Motor Activity
Locomotor activity
Drug Administration Schedule
Rheumatology
Internal medicine
medicine
Animals
Orthopedics and Sports Medicine
Rheumatoid arthritis
Motor function
Protein Kinase Inhibitors
Janus Kinases
Spontaneous locomotor activity
Behavior
Animal

Dose-Response Relationship
Drug

business.industry
Interleukin-6
Rodent model
medicine.disease
Adjuvant-induced arthritis
Arthritis
Experimental

Adjuvant induced arthritis
Surgery
Hyperalgesia
Rats
Inbred Lew

Joints
medicine.symptom
Inflammation Mediators
business
Janus kinase
Biomarkers
Research Article
Signal Transduction
Zdroj: BMC Musculoskeletal Disorders
ISSN: 1471-2474
DOI: 10.1186/s12891-015-0802-0
Popis: Background Rheumatoid arthritis (RA) is a chronic inflammatory disease that leads to joint destruction, disability, and decreased quality of life (QOL). Inhibition of Janus kinase (JAK) signaling ameliorates articular inflammation and joint destruction in animal models of RA, but its effects on behaviors indicating well-being are poorly understood. In this study, we evaluated the effect of JAK inhibition on spontaneous locomotor activity in rats with adjuvant-induced arthritis, a rodent model of RA. Methods Arthritis was induced in male Lewis rats by a single subcutaneous injection of Freund’s complete adjuvant. The novel JAK inhibitor JTE-052 was orally administered for 7 days after the onset of arthritis. Results Induction of arthritis suppressed the spontaneous locomotor activity of the rats. Administration of JTE-052 completely improved the spontaneous locomotor activity, with partial reductions in articular inflammation and joint destruction. Hyperalgesia and motor functions were also improved, but the efficacy was not complete. However, serum interleukin (IL)-6 levels were completely decreased at 4 h after administration of the first dose of JTE-052. Conclusions This study demonstrated that JAK inhibition improved the spontaneous locomotor activity of rats with adjuvant-induced arthritis, in association with amelioration of pain and physical dysfunction as a consequence of suppression of joint inflammation. Moreover, although further studies are needed, there was possible participation of IL-6 downregulation in the improvement of locomotor activity by JAK inhibition.
Databáze: OpenAIRE